Moreover, it has been demonstrated that B1R activation of PKC isoforms leads to the phosphorylation of ERK1/2 in estrogen-sensitive breast cancer cells, accompanied by an increase in tumor cell proliferation [43]. Here, PRRT2 is linked to neoplasm.